China has rapidly emerged as one of the world’s most dynamic sources of biotech innovation, reshaping global partnering, licensing, and investment strategies. This super session at Nordic Life Science Days 2026 brings together international pharma leaders, investors, and biotech executives to explore how cross-border dealmaking is evolving, what is driving the rise of Chinese innovation, and how Nordic and global companies can position themselves in this increasingly interconnected ecosystem.